Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 18 Apr 2012
At a glance
- Drugs Fadrozole; Letrozole
- Indications Advanced breast cancer
- Focus Adverse reactions
- 18 Apr 2012 Actual end date (Dec 2005) added as reported by ClinicalTrials.gov.
- 17 Apr 2012 Actual patient number is 17 according to ClinicalTrials.gov.
- 07 Sep 2007 Status changed from in progress to completed.